Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancer.
Int J Cancer
; 148(10): 2579-2593, 2021 May 15.
Article
in En
| MEDLINE
| ID: mdl-33210294
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Int J Cancer
Year:
2021
Type:
Article
Affiliation country:
Belgium